Albert Y. Chan
102 Pokfulam Road
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver disease.
Journal: Annals of hepatology
Published: September 25, 2025
The rise of transplant oncology in primary liver cancer and metastatic disease.
Journal: Hepatology (Baltimore, Md.)
Published: September 18, 2025
Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: April 30, 2025
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma.
Journal: JAMA oncology
Published: September 26, 2024
Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: July 04, 2024
Correlation of pathological examination with indocyanine green (ICG) intensity gradients: a prospective study in patients with liver tumor.
Journal: Surgical endoscopy
Published: December 14, 2023
Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.
Journal: Langenbeck's archives of surgery
Published: December 13, 2023
Tissue Stabilization, Bacterial Adhesion, and Stem Cell Viability in Trans-cinnamaldehyde-conditioned Dentin.
Journal: Journal of endodontics
Published: July 14, 2023
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.
Journal: Liver cancer
Published: March 14, 2023
Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: November 27, 2022
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: August 17, 2022
Commentary on "Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center".
Journal: Surgery
Published: November 30, 2021
Last Updated: 09/26/2026